Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy

Overview of attention for article published in Orphanet Journal of Rare Diseases, December 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 3 news outlets
twitter: 4 X users
patent: 2 patents

facebook: 2 Facebook pages
reddit: 1 Redditor

Citations

dimensions_citation: 75 Dimensions

Readers on

mendeley: 135 Mendeley

Summary News X Patents Facebook Reddit Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

Universo de enfermedades, 03 Apr 2015

Charcot-Marie-Tooth tipo 1A: PXT3003 downregulates PMP22 sobre expresión y mejora la mielinización, axonal y los parámetros…

Fabrice Fafa, 13 Jan 2015

Ça fait longtemps que j'avais pas eu mon nom dans un article !!!

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.